Novocure Ltd.
(NASDAQ : NVCR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.07%59.750.8%$507.00m
MDTMedtronic PLC
-0.78%80.970.6%$451.61m
ISRGIntuitive Surgical, Inc.
0.99%425.952.5%$398.82m
ALGNAlign Technology, Inc.
1.67%259.726.3%$387.11m
TMOThermo Fisher Scientific Inc.
1.74%211.451.0%$344.90m
BDXBecton, Dickinson and Company
1.05%222.121.1%$343.99m
SYKStryker Corporation
0.40%159.381.3%$249.01m
BAXBaxter International Inc.
1.19%67.841.7%$245.83m
BSXBoston Scientific Corporation
0.45%26.951.1%$231.57m
EWEdwards Lifesciences Corporation
1.25%136.011.2%$198.16m
ZBHZimmer Biomet Holdings, Inc.
1.28%120.241.7%$178.30m
XRAYDENTSPLY International Inc.
1.14%58.813.0%$144.11m
ABMDABIOMED, Inc.
0.30%271.283.3%$133.73m
VARVarian Medical Systems, Inc.
1.46%121.939.1%$132.15m
IDXXIDEXX Laboratories, Inc.
1.51%185.933.7%$125.30m

Company Profile

Novocure Ltd. operates as a commercial-stage oncology company, which offers devices for continuous home use by patients. It develops novottf-100A, a portable non-invasive investigational device for cancer treatment using tumor treating fields. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.